Literature DB >> 19036472

Can the use of a rapid polymerase chain screening method decrease the incidence of nosocomial meticillin-resistant Staphylococcus aureus?

M A Aldeyab1, M P Kearney, C M Hughes, M G Scott, M M Tunney, D F Gilpin, M J Devine, J D Watson, A Gardiner, C Funston, K Savage, J C McElnay.   

Abstract

Rapid detection of MRSA may be important for the control of MRSA spread in hospitals. The aim of this investigation was to compare the use of a rapid polymerase chain reaction (PCR) screening method with standard culture for the detection of meticillin-resistant Staphylococcus aureus (MRSA) colonisation and to determine its impact on the incidence of MRSA in two hospital wards. During the first phase of the investigation (four months), patients in a surgical ward were screened using the rapid PCR technique and patients in a medical/cardiology ward were screened with standard culture methods. During the second phase of the investigation (four months), MRSA screening methods were switched between the two wards. An audit of infection control practices on each ward was made at the end of each phase in order to check whether any changes had occurred that might influence the risks of MRSA transmission. Use of the rapid PCR method significantly reduced the median time between swabs being taken, to the results being telephoned to the wards (excluding weekends), from 47 to 21 h (P<0.001). However, comparison of MRSA incidence during use of PCR (20/1000 bed-days) and culture methods (22.1/1000 bed-days) revealed no significant difference in incidence on the surgical ward (P=0.69). Regarding the medical/cardiology ward, analysis of data was complicated by an increase in the detection of MRSA during the PCR phase (P<0.05). The study demonstrated that rapid PCR can significantly reduce the turnaround times but reducing the time between swabs being taken to results being telephoned to the ward is still not sufficient to limit the transmission of MRSA.

Entities:  

Mesh:

Year:  2008        PMID: 19036472     DOI: 10.1016/j.jhin.2008.10.011

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  6 in total

1.  Cepheid Xpert MRSA cycle threshold in discordant colonization results and as a quantitative measure of nasal colonization burden.

Authors:  Edward Stenehjem; David Rimland; Emily K Crispell; Cortney Stafford; Robert Gaynes; Sarah W Satola
Journal:  J Clin Microbiol       Date:  2012-03-21       Impact factor: 5.948

Review 2.  Current diagnostic tools for methicillin-resistant Staphylococcus aureus infections.

Authors:  Julianna Kurlenda; Mariusz Grinholc
Journal:  Mol Diagn Ther       Date:  2010-04-01       Impact factor: 4.074

3.  Dutch guideline on the laboratory detection of methicillin-resistant Staphylococcus aureus.

Authors:  M F Q Kluytmans-van den Bergh; M C Vos; B M W Diederen; C M J E Vandenbroucke-Grauls; A Voss; J A J W Kluytmans
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-07-27       Impact factor: 3.267

4.  Clinical application of real-time PCR to screening critically ill and emergency-care surgical patients for methicillin-resistant Staphylococcus aureus: a quantitative analytical study.

Authors:  M Trent Herdman; Duncan Wyncoll; Eugene Halligan; Penelope R Cliff; Gary French; Jonathan D Edgeworth
Journal:  J Clin Microbiol       Date:  2009-10-21       Impact factor: 5.948

5.  Direct detection of Staphylococcus osteoarticular infections by use of Xpert MRSA/SA SSTI real-time PCR.

Authors:  Anne Dubouix-Bourandy; Aymard de Ladoucette; Valerie Pietri; Nazim Mehdi; David Benzaquen; Régis Guinand; Jean-Marc Gandois
Journal:  J Clin Microbiol       Date:  2011-10-12       Impact factor: 5.948

Review 6.  Clinical effectiveness of rapid tests for methicillin resistant Staphylococcus aureus (MRSA) in hospitalized patients: a systematic review.

Authors:  Julie Polisena; Stella Chen; Karen Cimon; Sarah McGill; Kevin Forward; Michael Gardam
Journal:  BMC Infect Dis       Date:  2011-12-12       Impact factor: 3.090

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.